Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT02811510
PHASE1
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I
Sponsor: Yale University
View on ClinicalTrials.gov
Summary
The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2016-06
Completion Date
2026-12
Last Updated
2025-06-10
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Placebo
Placebo pill (no active cannabinoids)
DRUG
Dronabinol
10 mg capsule of Dronabinol will be administered orally.
Locations (1)
Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine
West Haven, Connecticut, United States